Claims
- 1. A compound of the following formula:RC(═O)NH—X—[NHC(═NH)NHC(═NH)NH—X—]nNHC(═O)R wherein:n is a whole number in the range of 1 to 100; X is saturated or unsaturated alkyl, cycloalkyl, alkyl substituted with cycloalkyl, aryl, or aralkyl, with the proviso that the X groups contain 1 to 40 carbon atoms (C1 to C40) and are unsubstituted or substituted with any number of N, O, S, P, B, F, Cl, Br, or I; and R is a saturated or unsaturated alkyl (C1 to C50), cycloalkyl (C3 to C50), alkyl substituted with cycloalkyl, polyethylene oxide having a molecular weight of 50 to 10,000, polypropylene oxide having a molecular weight of 50 to 10,000, any combination of the above groups, unsubstituted aralkyl, aralkyl substituted with any number of N, O, S, P, B, F, Cl, Br, or I, unsubstituted aryl, or aryl substituted with any number of N, O, S, P, B, F, Cl, Br, or I, optionally including one or more amide, urea or other covalent linking functional groups.
- 2. The compound of claim 1, wherein R is polyethylene oxide.
- 3. A pharmaceutical composition comprising a microbiocidally effective amount of the compound of claim 1.
- 4. An ophthalmic composition for disinfecting contact lenses, comprising:a compound of the following formula in an amount effective to disinfect contact lenses: RC(═O)NH—X—[NHC(═NH)NHC(═NH)NH—X—]nNHC(═O)R wherein: n is a whole number in the range of 1 to 100; X is saturated or unsaturated alkyl, cycloalkyl, alkyl substituted with cycloalkyl, aryl, or aralkyl, with the proviso that the X groups contain 1 to 40 carbon atoms (C1 to C40) and are unsubstituted or substituted with any number of N, O, S, P, B, F, Cl, Br, or I; and R is a saturated or unsaturated alkyl (C1 to C50), cycloalkyl (C3 to C50), alkyl substituted with cycloalkyl, polyethylene oxide having a molecular weight of 50 to 10,000 (M.W. 50-10,000), polypropylene oxide having a molecular weight of 50 to 10,000 (M.W. 50-10,000), any combination of the above groups, unsubstituted aralkyl, aralkyl substituted with any number of N, O, S, P, B, F, Cl, Br, or I, unsubstituted aryl, or aryl substituted with any number of N, O, S, P, B, F, Cl, Br, or I, optionally including one or more amide, urea or other covalent linking functional groups; and an ophthalmically acceptable vehicle for said compound.
- 5. A method of disinfecting a contact lens which comprises immersing the lens in the composition of claim 4 for a time sufficient to disinfect the lens.
- 6. A method of preserving a pharmaceutical composition from microbial contamination which comprises including in the composition a preservative effective amount of a compound of the following formula:RC(═O)NH—X—[NHC(═NH)NHC(═NH)NH—X—]nNHC(═O)R wherein:n is a whole number in the range of 1 to 100; X is saturated or unsaturated alkyl, cycloalkyl, alkyl substituted with cycloalkyl, aryl, or aralkyl, with the proviso that the X groups contain 1 to 40 carbon atoms (C1 to C40) and are unsubstituted or substituted with any number of N, O, S, P, B, F, Cl, Br, or I; and R is a saturated or unsaturated alkyl (C1 to C50), cycloalkyl (C3 to C50), alkyl substituted with cycloalkyl, polyethylene oxide having a molecular weight of 50 to 10,000 (M.W. 50-10,000), polypropylene oxide having a molecular weight of 50 to 10,000 (M.W. 50-10,000), any combination of the above groups, unsubstituted aralkyl, aralkyl substituted with any number of N, O, S, P, B, F, Cl, Br, or I, unsubstituted aryl, or aryl substituted with any number of N, O, S, P, B, F, Cl, Br, or I, optionally including one or more amide, urea or other covalent linking functional groups.
- 7. A method according to claim 6, wherein the composition is an ophthalmic pharmaceutical composition.
- 8. A method according to claim 6, wherein the composition is an otic pharmaceutical composition.
Parent Case Info
This application is a 371 of PCT/US99/30208, filed Dec. 17, 1999 and is a continuation of Ser. No. 60/112,971, filed Dec. 18, 1998.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/US99/30208 |
|
WO |
00 |
9/19/2000 |
9/19/2000 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO00/35861 |
6/6/2000 |
WO |
A |
US Referenced Citations (6)
Number |
Name |
Date |
Kind |
3799988 |
Hashimoto et al. |
Mar 1974 |
|
4891423 |
Stockel |
Jan 1990 |
|
4954636 |
Merianos et al. |
Sep 1990 |
|
5149524 |
Sherba et al. |
Sep 1992 |
|
5573726 |
Dassanayake et al. |
Nov 1996 |
|
5741886 |
Stockel et al. |
Apr 1998 |
|
Foreign Referenced Citations (5)
Number |
Date |
Country |
2098472 |
Dec 1993 |
CA |
WO 9736487 |
Oct 1997 |
WO |
WO 9820913 |
May 1998 |
WO |
WO 9820738 |
May 1998 |
WO |
WO 9830248 |
Jul 1998 |
WO |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/112971 |
Dec 1998 |
US |